Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (41)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jones, G.
Right arrow Articles by Ahern, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, G.
Right arrow Articles by Ahern, M.
Related Collections
Right arrow Diagnostics and Imaging Procedures
Right arrow Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2003; 42: 6-13
© 2003 British Society for Rheumatology

The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trials

G. Jones, J. Halbert1, M. Crotty1, E. M. Shanahan2, M. Batterham1 and M. Ahern2

Menzies Centre for Population Health Research, GPO Box 252-23, Hobart, Tasmania 7000,
1 Department of Rehabilitation and Aged Care and
2 Department of Medicine, Flinders University, Bedford Park, South Australia 5042, Australia

Objective. To undertake a systematic review of randomized placebo-controlled trials to assess and rank the efficacy of pharmacological interventions in preventing radiological progression of rheumatoid arthritis.

Methods. The two outcome measures were the weighted standardized mean difference and the odds of progression of X-ray scores pooled as close to 12 months as possible to minimize heterogeneity.

Results. A total of 38 trials were identified. Of these, 13 were excluded, leaving data on 3907 subjects. Infliximab, cyclosporin, sulphasalazine, leflunomide, methotrexate, parenteral gold, corticosteroids, auranofin and interleukin 1 receptor antagonist were statistically better than placebo in terms of change in erosion scores. All agents were equivalent statistically, with the exception of infliximab (which was superior to the last five agents). There were similar findings for the odds of progression, with the exception of auranofin (P=0.06) and the infliximab–methotrexate comparison (P=0.07). Other agents did not reach statistical significance in either outcome measure. With the exception of the antimalarials, the magnitude of the effect was consistent with the effect seen in short-term disease activity trials.

Conclusion. There is published evidence which supports the efficacy of nine agents in decreasing radiological progression in rheumatoid arthritis.

KEY WORDS: Rheumatoid arthritis, Meta-analysis, Therapy, Radiographic, Trial, Placebo.

Correspondence to: G. Jones. E-mail: g.jones{at}utas.edu.au


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
C.-M. Wong, Y. Ko, and A. Chan
Clinically Significant Drug-Drug Interactions Between Oral Anticancer Agents and Nonanticancer Agents: Profiling and Comparison of Two Drug Compendia
Ann. Pharmacother., December 1, 2008; 42(12): 1737 - 1748.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
S. M van der Kooij, J. K de Vries-Bouwstra, Y. P M Goekoop-Ruiterman, D. van Zeben, P. J S M Kerstens, A. H Gerards, J. H L M van Groenendael, J. M W Hazes, F. C Breedveld, C. F Allaart, et al.
Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score
Ann Rheum Dis, October 1, 2007; 66(10): 1356 - 1362.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
M E Weinblatt
Rheumatoid arthritis in 2003: where are we now with treatment?
Ann Rheum Dis, November 1, 2003; 62(90002): ii94 - 96.
[Full Text] [PDF]

Home page
 Evid. Based Med.Home page
ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB
Evid. Based Med., September 1, 2003; 8(5): 131 - 131.
[Full Text] [PDF]

Home page
 Evid. Based Nurs.Home page
OTHER ARTICLES NOTED (24 Jan 03 to 18 Apr 03)
Evid. Based Nurs., July 1, 2003; 6(3): e1 - 12.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.